Age associated susceptibility to SARS-CoV-2 infection in the K18-hACE2 transgenic mouse model

被引:0
|
作者
Dwivedi, Varun [1 ]
Shivanna, Vinay [2 ]
Gautam, Shalini [2 ]
Delgado, Jennifer [1 ]
Hicks, Amberlee [1 ]
Argonza, Marco [1 ]
Meredith, Reagan [1 ]
Turner, Joanne [3 ]
Martinez-Sobrido, Luis [1 ]
Torrelles, Jordi B. [2 ,4 ]
Kulkarni, Viraj [1 ]
机构
[1] Texas Biomed Res Inst, Dis Intervent & Prevent Program, San Antonio, TX 78227 USA
[2] Texas Biomed Res Inst, Populat Hlth Program, San Antonio, TX 78227 USA
[3] Texas Biomed Res Inst, Host Pathogen Interact Program, San Antonio, TX 78227 USA
[4] Texas Biomed Res Inst, I CARE, San Antonio, TX USA
基金
美国国家卫生研究院;
关键词
COVID-19; SARS-CoV-2; infection; Aging; Cytokine storm; K18-hACE2 transgenic mouse;
D O I
10.1007/s11357-024-01102-6
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still an ongoing global health crisis. Clinical data indicate that the case fatality rate (CFR) is age dependent, with a higher CFR percentage in the elderly population. We compared the pathogenesis of SARS-CoV-2 in young and aged K18-hACE2 transgenic mice. We evaluated morbidity, mortality, viral titers, immune responses, and histopathology in SARS-CoV-2-infected young and old K18-hACE2 transgenic mice. Within the limitation of having a low number of mice per group, our results indicate that SARS-CoV-2 infection resulted in slightly higher morbidity, mortality, and viral replication in the lungs of old mice, which was associated with an impaired IgM response and altered cytokine and chemokine profiles. Results of this study increase our understanding of SARS-CoV-2 infectivity and immuno-pathogenesis in the elderly population.
引用
收藏
页码:2901 / 2913
页数:13
相关论文
共 50 条
  • [41] Chronological brain lesions after SARS-CoV-2 infection in hACE2-transgenic mice
    Vidal, Enric
    Lopez-Figueroa, Carlos
    Rodon, Jordi
    Perez, Monica
    Brustolin, Marco
    Cantero, Guillermo
    Guallar, Victor
    Izquierdo-Useros, Nuria
    Carrillo, Jorge
    Blanco, Julia
    Clotet, Bonaventura
    Vergara-Alert, Julia
    Segales, Joaquim
    VETERINARY PATHOLOGY, 2022, 59 (04) : 613 - 626
  • [42] Intranasal administration of BReC-CoV-2 COVID-19 vaccine protects K18-hACE2 mice against lethal SARS-CoV-2 challenge
    Wong, Ting Y.
    Lee, Katherine S.
    Russ, Brynnan P.
    Horspool, Alexander M.
    Kang, Jason
    Winters, Michael T.
    Wolf, M. Allison
    Rader, Nathaniel A.
    Miller, Olivia A.
    Shiflett, Morgane
    Izac, Jerilyn
    Varisco, David
    Sen-Kilic, Emel
    Cunningham, Casey
    Cooper, Melissa
    Cyphert, Holly A.
    Barbier, Mariette
    Martinez, Ivan
    Bevere, Justin R.
    Ernst, Robert K.
    Damron, F. Heath
    NPJ VACCINES, 2022, 7 (01)
  • [43] Protection of K18-hACE2 Mice against SARS-CoV-2 Challenge by a Capsid Virus-like Particle-Based Vaccine
    Myeni, Sebenzile K.
    Leijs, Anouk A.
    Bredenbeek, Peter J.
    Morales, Shessy Torres
    Linger, Marissa E.
    Fougeroux, Cyrielle
    van Zanen-Gerhardt, Sophie
    Zander, Serge A. L.
    Sander, Adam F.
    Kikkert, Marjolein
    VACCINES, 2024, 12 (07)
  • [44] Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice
    Paull, Jeremy R. A.
    Luscombe, Carolyn A.
    Castellarnau, Alex
    Heery, Graham P.
    Bobardt, Michael D.
    Gallay, Philippe A.
    VIRUSES-BASEL, 2021, 13 (08):
  • [45] RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC Challenge
    Wong, Ting Y.
    Russ, Brynnan P.
    Lee, Katherine S.
    Miller, Olivia A.
    Kang, Jason
    Cooper, Melissa
    Winters, Michael T.
    Rodriguez-Aponte, Sergio A.
    Dalvie, Neil C.
    Johnston, Ryan S.
    Rader, Nathaniel A.
    Wong, Zeriel Y.
    Cyphert, Holly A.
    Martinez, Ivan
    Shaligram, Umesh
    Batwal, Saurabh
    Lothe, Rakesh
    Chandrasekaran, Rahul
    Nagar, Gaurav
    Rajurkar, Meghraj
    Rao, Harish
    Bevere, Justin R.
    Barbier, Mariette
    Love, J. Christopher
    Damron, F. Heath
    MSPHERE, 2022, 7 (04)
  • [46] A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
    Zhou, Xiaoyang
    Sun, Weiyang
    Zhang, Yu
    Gu, Hongjing
    Wang, Ruixuan
    Xie, Peng
    Zhu, Yunkai
    Qiu, Minyue
    Ding, Xiaoyan
    Wang, Hui
    Gao, Yuwei
    Li, Jintao
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [47] NRICM101 ameliorates SARS-CoV-2-S1-induced pulmonary injury in K18-hACE2 mice model
    Wei, Wen-Chi
    Tsai, Keng-Chang
    Liaw, Chia-Ching
    Chiou, Chun-Tang
    Tseng, Yu-Hwei
    Liao, Geng-You
    Lin, Yu-Chi
    Chiou, Wen-Fei
    Liou, Kuo-Tong
    Yu, I-Shing
    Shen, Yuh-Chiang
    Su, Yi-Chang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [48] Mouse-Adapted SARS-CoV-2 MA10 Strain Displays Differential Pulmonary Tropism and Accelerated Viral Replication, Neurodissemination, and Pulmonary Host Responses in K18-hACE2 Mice
    Thieulent, Come J.
    Dittmar, Wellesley
    Balasuriya, Udeni B. R.
    Crossland, Nicholas A.
    Wen, Xue
    Richt, Juergen A.
    Carossino, Mariano
    MSPHERE, 2023, 8 (01)
  • [49] Age-associated SARS-CoV-2 breakthrough infection and changes in immune response in a mouse model
    Chen, Yanxia
    Li, Can
    Liu, Feifei
    Ye, Zhanhong
    Song, Wenchen
    Lee, Andrew C. Y.
    Shuai, Huiping
    Lu, Lu
    To, Kelvin Kai-Wang
    Chan, Jasper Fuk-Woo
    Zhang, Anna Jinxia
    Chu, Hin
    Yuen, Kwok-Yung
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 368 - 383
  • [50] The Protective Efficacy of a SARS-CoV-2 Vaccine Candidate B.1.351V against Several Variant Challenges in K18-hACE2 Mice
    Yang, Jie
    Fan, Huifen
    Yang, Anna
    Wang, Wenhui
    Wan, Xin
    Lin, Fengjie
    Yang, Dongsheng
    Wu, Jie
    Wang, Kaiwen
    Li, Wei
    Cai, Qian
    You, Lei
    Pang, Deqin
    Lu, Jia
    Guo, Changfu
    Shi, Jinrong
    Sun, Yan
    Li, Xinguo
    Duan, Kai
    Shen, Shuo
    Meng, Shengli
    Guo, Jing
    Wang, Zejun
    VACCINES, 2024, 12 (07)